• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.32% Nasdaq Down0.62%

    Amarin Corporation plc (AMRN)

    1.83 Down 0.02(1.08%) Apr 29, 4:00PM EDT
    ProfileGet Profile for:
    Amarin Corporation plc
    2 Pembroke House
    Upper Pembroke Street 28-32
    Dublin, 2
    Ireland - Map
    Phone: 353 1 669 9020
    Website: http://www.amarincorp.com

    Index Membership:N/A
    Industry:Drug Manufacturers - Other
    Full Time Employees:201

    Business Summary 

    Amarin Corporation plc, a biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States. The company’s lead product includes Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It is also involved in developing Vascepa for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was founded in 1989 and is based in Dublin, Ireland.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Amarin Corporation plc

    Key Executives 
    Mr. John F. Thero , 55
    Chief Exec. Officer, Pres, Assistant Sec. and Director
    Dr. Steven B. Ketchum Ph.D., 51
    Chief Scientific Officer, Sr. VP and Pres of R&D
    Mr. Joseph T. Kennedy J.D., 48
    Exec. VP of Strategic Initiatives and Gen. Counsel
    Mr. Alan D. Cooke , 45
    Chief Operating Officer
    Mr. Frederick W. Ahlholm CPA, 50
    VP of Fin. and Admin.
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders